550 related articles for article (PubMed ID: 25912702)
21. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.
Kratz CP; Rapisuwon S; Reed H; Hasle H; Rosenberg PS
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):83-9. PubMed ID: 21500339
[TBL] [Abstract][Full Text] [Related]
22. PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype.
Bertola DR; Pereira AC; Albano LM; De Oliveira PS; Kim CA; Krieger JE
Genet Test; 2006; 10(3):186-91. PubMed ID: 17020470
[TBL] [Abstract][Full Text] [Related]
23. Extensive abdominal lipomatosis in a patient with Noonan/LEOPARD syndrome (Noonan syndrome-Multiple Lentigines).
Piard J; Verloes A; Cavé H; Peuchmaur M; Bennaceur S; Leheup B
Am J Med Genet A; 2012 Jun; 158A(6):1406-10. PubMed ID: 22528600
[TBL] [Abstract][Full Text] [Related]
24. Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants.
Ranza E; Guimier A; Verloes A; Capri Y; Marques C; Auclair M; Mathieu-Dramard M; Morin G; Thevenon J; Faivre L; Thauvin-Robinet C; Innes AM; Dyment DA; Vigouroux C; Amiel J
Clin Genet; 2020 Jul; 98(1):10-18. PubMed ID: 32233106
[TBL] [Abstract][Full Text] [Related]
25. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
[TBL] [Abstract][Full Text] [Related]
26. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
[TBL] [Abstract][Full Text] [Related]
27. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
Yaoita M; Niihori T; Mizuno S; Okamoto N; Hayashi S; Watanabe A; Yokozawa M; Suzumura H; Nakahara A; Nakano Y; Hokosaki T; Ohmori A; Sawada H; Migita O; Mima A; Lapunzina P; Santos-Simarro F; García-Miñaúr S; Ogata T; Kawame H; Kurosawa K; Ohashi H; Inoue S; Matsubara Y; Kure S; Aoki Y
Hum Genet; 2016 Feb; 135(2):209-22. PubMed ID: 26714497
[TBL] [Abstract][Full Text] [Related]
28. Noonan syndrome: Severe phenotype and PTPN11 mutations.
Carrasco Salas P; Gómez-Molina G; Carreto-Alba P; Granell-Escobar R; Vázquez-Rico I; León-Justel A
Med Clin (Barc); 2019 Jan; 152(2):62-64. PubMed ID: 29703613
[TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukemia developing in a patient with Noonan syndrome harboring a PTPN11 germline mutation.
Sakamoto K; Imamura T; Asai D; Goto-Kawashima S; Yoshida H; Fujiki A; Furutani A; Ishida H; Aoki Y; Hosoi H
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e136-9. PubMed ID: 24072241
[TBL] [Abstract][Full Text] [Related]
30. LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies.
Santoro C; Pacileo G; Limongelli G; Scianguetta S; Giugliano T; Piluso G; Ragione FD; Cirillo M; Mirone G; Perrotta S
BMC Med Genet; 2014 Apr; 15():44. PubMed ID: 24767283
[TBL] [Abstract][Full Text] [Related]
31. Rasopathies case report: concurrence of two pathogenic variations de novo in NF1 and KRAS genes in a patient.
Baquedano Lobera I; Izquierdo Álvarez S; Oliván Del Cacho MJ
BMC Pediatr; 2019 Apr; 19(1):92. PubMed ID: 30953504
[TBL] [Abstract][Full Text] [Related]
32. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
[TBL] [Abstract][Full Text] [Related]
33. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
[TBL] [Abstract][Full Text] [Related]
34. Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation.
Rankin J; Short J; Turnpenny P; Castle B; Hanemann CO
Am J Med Genet A; 2013 Aug; 161A(8):2027-9. PubMed ID: 23813970
[TBL] [Abstract][Full Text] [Related]
35. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome.
Koh AL; Tan ES; Brett MS; Lai AHM; Jamuar SS; Ng I; Tan EC
Mol Genet Genomic Med; 2019 Apr; 7(4):e00581. PubMed ID: 30784236
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune liver disease in Noonan Syndrome.
Loddo I; Romano C; Cutrupi MC; Sciveres M; Riva S; Salpietro A; Ferraù V; Gallizzi R; Briuglia S
Eur J Med Genet; 2015 Mar; 58(3):188-90. PubMed ID: 25595571
[TBL] [Abstract][Full Text] [Related]
39. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
Dereure O
Ann Dermatol Venereol; 2008; 135(8-9):624-5. PubMed ID: 18789305
[No Abstract] [Full Text] [Related]
40. [Multiple granular cell tumours in a patient with Noonan's syndrome and juvenile myelomonocytic leukaemia].
Castagna J; Clerc J; Dupond AS; Laresche C
Ann Dermatol Venereol; 2017 Nov; 144(11):705-711. PubMed ID: 28728859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]